Securities code: Winner Medical Co.Ltd(300888) securities abbreviation: Winner Medical Co.Ltd(300888) Announcement No.: 2022007 Winner Medical Co.Ltd(300888)
Announcement on the progress of repurchasing shares of the company
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Winner Medical Co.Ltd(300888) (hereinafter referred to as “the company”) held the third meeting of the third board of directors and the third meeting of the third board of supervisors on September 17, 2021 to consider and adopt the proposal on share repurchase scheme. Based on the confidence in future development and the judgment of its own value, in order to strengthen the confidence of investors and further build a more stable and high-quality management team, Establish and improve the company’s long-term incentive mechanism, fully mobilize the enthusiasm of the management and core backbone, improve team cohesion, effectively closely combine the interests of shareholders, the company and the personal interests of core employees, and promote the long-term sustainable development of the company. The company plans to use its own funds of RMB Tus-Design Group Co.Ltd(300500) million to repurchase the company’s shares at a price of no more than 116 yuan / share, Based on the above repurchase amount range and repurchase price ceiling, the number of repurchases shall be no less than 2586200 shares and no more than 4310300 shares, accounting for no less than 0.6064% and no more than 1.0107% of the total share capital of the company. For details, please refer to the announcement on share repurchase scheme disclosed by the company on September 22, 2021 and the repurchase report disclosed on September 29, 2021.
According to the relevant provisions of Shenzhen Stock Exchange self regulatory guidelines for listed companies No. 9 – share repurchase, the progress of the company’s share repurchase is disclosed as follows:
1、 Progress of share repurchase
As of February 28, 2022, the company has repurchased 4765659 shares of the company through centralized bidding trading through the special securities repurchase account, accounting for 1.1174% of the total share capital of the company. The maximum transaction price is 82.42 yuan / share, the minimum transaction price is 70.80 yuan / share, and the total transaction amount is 36686388954 yuan (excluding transaction costs). This share repurchase complies with relevant laws and regulations, departmental rules, normative documents, business rules and the company’s share repurchase plan.
2、 Other instructions
(I) the time, price and quantity of the company’s initial share repurchase comply with the relevant provisions of Articles 17, 18 and 19 of the guidelines for self discipline supervision of listed companies of Shenzhen Stock Exchange No. 9 – share repurchase. 1. The company has not repurchased the company’s shares within the following periods:
(1) If the disclosure date of the company’s annual report and semi annual report is delayed due to special reasons within ten trading days before the announcement, it shall be calculated from the ten trading days before the original scheduled announcement date;
(2) Within ten trading days before the announcement of the company’s quarterly report, performance forecast and performance express;
(3) From the date of occurrence of major events that may have a significant impact on the company’s stock trading price or in the process of decision-making to the date of disclosure according to law;
(4) Other circumstances stipulated in the repurchase report of the CSRC, Shenzhen Stock Exchange and the company. 2. The company has not entrusted to buy back shares at the following trading hours:
(1) Opening call auction;
(2) Within half an hour before closing;
(3) A trading day on which the stock price has no limit on rise or fall.
The price of repurchased shares is not the price limited by the trading increase of the company’s shares on the same day.
3. The Company repurchased its shares for the first time on September 28, 2021. The cumulative trading volume of the company’s shares in the five trading days before the date of the first repurchase was 11893150 shares, and the maximum number of shares repurchased by the company every five trading days was 1116322 shares (October 27, 2021 – November 2, 2021), It does not exceed 25% (2973287 shares) of the company’s cumulative trading volume of shares in the five trading days before the date of the first share repurchase. (II) the company will continue to implement the repurchase plan during the repurchase period in combination with the market situation, and timely perform the obligation of information disclosure in accordance with the requirements of relevant laws and regulations, departmental rules, normative documents and business rules. It is hereby announced.
Winner Medical Co.Ltd(300888) board of directors March 3, 2002
